Elevance Health ELV
$425.62 −$6.38 (-1.48%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $425.62 0.00%
Open$421.47
Prev close$432.00
Day range$421.47 – $430.69
Volume1.44M
Market cap$91.96B
P/E (TTM)18.1
Dividend yield1.61%
ELV Stock News
Headlines matching Elevance Health or the ELV ticker, most recent first.
- Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $488
- UBS Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $460
- Wells Fargo Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $473
- UBS Group Employee Benefits Survey: Elevance Health (ELV.US) Leads as U.S. Employers Prepare for Rising Healthcare Costs Positive
- BofA Securities Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $480 Positive
- Barclays Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $457
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Shenzhen Edge Medical Co., Ltd. Class H (HK:2675), Elevance Health (ELV) and 4DMedical Ltd (AU:4DX)
- RBC Capital Maintains Elevance Health(ELV.US) With Hold Rating, Raises Target Price to $439 Positive
- Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $488 Positive
- Morgan Stanley Maintains Elevance Health(ELV.US) With Hold Rating, Maintains Target Price $404
- TD Cowen Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $465
- Leerink Partners Maintains Elevance Health(ELV.US) With Hold Rating, Raises Target Price to $395 Positive
- Jefferies Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $450 Positive
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), Alnylam Pharma (ALNY) and Elevance Health (ELV)
- A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $393 to $475
No comments yet — be the first to weigh in on ELV.
Sign in to join the discussion.